Mark L. Messonnier

3.7k total citations · 1 hit paper
47 papers, 2.8k citations indexed

About

Mark L. Messonnier is a scholar working on Health, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Mark L. Messonnier has authored 47 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Health, 22 papers in Epidemiology and 14 papers in Economics and Econometrics. Recurrent topics in Mark L. Messonnier's work include Vaccine Coverage and Hesitancy (22 papers), Influenza Virus Research Studies (15 papers) and Healthcare Policy and Management (8 papers). Mark L. Messonnier is often cited by papers focused on Vaccine Coverage and Hesitancy (22 papers), Influenza Virus Research Studies (15 papers) and Healthcare Policy and Management (8 papers). Mark L. Messonnier collaborates with scholars based in United States, United Kingdom and France. Mark L. Messonnier's co-authors include Noelle‐Angelique Molinari, Ismael R. Ortega‐Sanchez, Eric Weintraub, W. Thompson, Carolyn B. Bridges, Pascale Wortley, Fangjun Zhou, Abigail Shefer, Lisa A. Prosser and Tracy A. Lieu and has published in prestigious journals such as JAMA, PLoS ONE and PEDIATRICS.

In The Last Decade

Mark L. Messonnier

47 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

2007 1.3k citations Noelle‐Angelique Molinari, Mark L. Messonnier et al. Vaccine profile →

Peers

Mark L. Messonnier

EPIDE

HEALT

Vittorio Demicheli Italy

Anthony T. Newall Australia

Ulla Griffiths United Kingdom

Alessandro Rivetti Italy

Anita Heywood Australia

Heath Kelly Australia

Pier Luigi Lopalco Italy

Angus Nicoll United Kingdom

Elizabeth T. Luman United States

Jim McMenamin United Kingdom

Vittorio Demicheli Italy

Mark L. Messonnier

2.9k ×1.6

EPIDE

1.1k ×1.1

HEALT

869 ×1.7

388 ×1.1

232 ×0.7

Citations per year, relative to Mark L. Messonnier Mark L. Messonnier (= 1×) peers Vittorio Demicheli

Countries citing papers authored by Mark L. Messonnier

Since Specialization

Citations

This map shows the geographic impact of Mark L. Messonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Messonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Messonnier more than expected).

Fields of papers citing papers by Mark L. Messonnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Messonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Messonnier. The network helps show where Mark L. Messonnier may publish in the future.

Co-authorship network of co-authors of Mark L. Messonnier

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Messonnier. A scholar is included among the top collaborators of Mark L. Messonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Messonnier. Mark L. Messonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lavelle, Tara A., Mark L. Messonnier, Shannon Stokley, et al.. (2019). Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States. Journal of Patient-Reported Outcomes. 3(1). 51–51. 13 indexed citations

Kamiya, Hajime, et al.. (2016). Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States. Vaccine. 34(15). 1832–1838. 20 indexed citations

Harvey, Michael J., Lisa A. Prosser, Mark L. Messonnier, & David W. Hutton. (2016). Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right. PLoS ONE. 11(6). e0156737–e0156737. 3 indexed citations

Chen, Weiwei, Mark L. Messonnier, & Fangjun Zhou. (2016). Trends in childhood vaccine purchase costs in the US public sector: 1996–2014. Vaccine. 34(39). 4706–4711. 3 indexed citations

Brown, Derek S., et al.. (2014). Parent attitudes about school-located influenza vaccination clinics. Vaccine. 32(9). 1043–1048. 13 indexed citations

Prosser, Lisa A., Katherine Payne, Donna Rusinak, Ping Shi, & Mark L. Messonnier. (2013). Using a Discrete Choice Experiment to Elicit Time Trade-Off and Willingness-to-Pay Amounts for Influenza Health-Related Quality of Life at Different Ages. PharmacoEconomics. 31(4). 305–315. 9 indexed citations

Prosser, Lisa A., Katherine Payne, Donna Rusinak, et al.. (2011). Valuing health across the lifespan: Health state preferences for seasonal influenza illnesses in patients of different ages. Value in Health. 14(1). 135–143. 27 indexed citations

Hicks, Katherine A., Amanda Honeycutt, Nathaniel Hupert, et al.. (2011). A Tool for the Economic Analysis of Mass Prophylaxis Operations With an Application to H1N1 Influenza Vaccination Clinics. Journal of Public Health Management and Practice. 17(1). E22–E28. 8 indexed citations

Gidengil, Courtney A., M. Maya Dutta-Linn, Mark L. Messonnier, Donna Rusinak, & Tracy A. Lieu. (2010). Financial Barriers to the Adoption of Combination Vaccines by Pediatricians. Archives of Pediatrics and Adolescent Medicine. 164(12). 1138–44. 6 indexed citations

10.

Brown, Derek S., F. Reed Johnson, Christine Poulos, & Mark L. Messonnier. (2009). Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 28(7). 1702–1708. 71 indexed citations

11.

Blewett, Lynn A., Gestur Davidson, Matthew D. Bramlett, Holly Rodin, & Mark L. Messonnier. (2008). The Impact of Gaps in Health Insurance Coverage on Immunization Status for Young Children. Health Services Research. 43(5p1). 1619–1636. 19 indexed citations

12.

Prosser, Lisa A., Megan A. O’Brien, Noelle‐Angelique Molinari, et al.. (2008). Non-Traditional Settings for Influenza Vaccination of Adults. PharmacoEconomics. 26(2). 163–178. 108 indexed citations

13.

Kolasa, Maureen, et al.. (2008). Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. American Journal of Infection Control. 36(8). 582–587. 14 indexed citations

14.

Dempsey, Amanda F., Anne E. Cowan, Shannon Stokley, et al.. (2008). The role of economic information in decision-making by the Advisory Committee on Immunization Practices. Vaccine. 26(42). 5389–5392. 12 indexed citations

15.

Lee, Grace M., Jeanne M. Santoli, Mark L. Messonnier, et al.. (2007). Gaps in Vaccine Financing for Underinsured Children in the United States. JAMA. 298(6). 638–638. 72 indexed citations

16.

Zhou, Fangjun, Jeanne M. Santoli, Mark L. Messonnier, et al.. (2005). Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001. Archives of Pediatrics and Adolescent Medicine. 159(12). 1136–1136. 125 indexed citations

17.

Rheingans, Richard, et al.. (2004). Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti. PubMed. 3(1). 2–2. 16 indexed citations

18.

Elbasha, Elamin H. & Mark L. Messonnier. (2003). Cost‐effectiveness analysis and health care resource allocation: decision rules under variable returns to scale. Health Economics. 13(1). 21–35. 43 indexed citations

19.

Bousquet, Jean, Rami Ben‐Joseph, Mark L. Messonnier, E. Alemao, & A. Lawrence Gould. (2002). A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clinical Therapeutics. 24(1). 1–20. 47 indexed citations

20.

Messonnier, Mark L., Phaedra S. Corso, Steven M. Teutsch, Anne C. Haddix, & Jeffrey R. Harris. (1999). An ounce of prevention … what are the returns?. American Journal of Preventive Medicine. 16(3). 248–263. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact